Serious Game for Parkinson's Disease Patients
Launched by INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE, FRANCE · Jun 8, 2015
Trial Information
Current as of June 23, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Parkinson's disease
- • Gait and balance disorders
- • Chronic bilateral deep brain stimulation of the subthalamic nucleus (\> 1 year).
- Exclusion Criteria:
- • Dementia
- • Ongoing severe medical condition that prevented assessments
About Institut National De La Santé Et De La Recherche Médicale, France
The Institut National de la Santé et de la Recherche Médicale (INSERM) is France's key public research organization dedicated to advancing knowledge in health and biomedical sciences. Established to foster innovation and improve public health outcomes, INSERM conducts a wide range of clinical trials and research initiatives aimed at translating scientific discoveries into effective medical treatments and interventions. With a focus on collaboration among researchers, healthcare professionals, and industry partners, INSERM plays a pivotal role in shaping health policies and enhancing the quality of care in France and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Paris, , France
Patients applied
Trial Officials
Marie-Laure Welter, MD, PhD
Principal Investigator
GHPS, APHP, Paris
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials